Herantis Pharma plc - Company & Market Research Reports

Herantis Pharma is a specialty pharmaceutical company based in Helsinki, Finland. It specializes in drugs for the treatment of dry eye, Parkinson's diseases, amyotrophic lateral sclerosis (ALS) and secondary lymphedema. They are developing selected drug candidates through late preclinical and early clinical stages. Herantis products in pipeline include Cis-UCA eye drops, CDNF for the treatment of Parkinson's Diseases ALS; and Lymfactin, which is in clinical trials for treating breast cancer.

Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Dermatitis - Pipeline Review, H2 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H2 2015

  • Report
  • 445 Pages
From
Dermatitis - Pipeline Review, H1 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H1 2015

  • Report
  • 381 Pages
From
Artificial Tears - Global Strategic Business Report - Product Thumbnail Image

Artificial Tears - Global Strategic Business Report

  • Report
  • 143 Pages
From
United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 260 Pages
From
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview  - Product Thumbnail Image

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview

  • Report
  • 208 Pages
From
Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • 204 Pages
From
Amyotrophic Lateral Sclerosis - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2027 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2027

  • Drug Pipelines
  • 300 Pages
From
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2018

  • Report
  • 487 Pages
From
Parkinson's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H1 2018

  • Report
  • 881 Pages
From
Parkinson's Disease Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Parkinson's Disease Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 854 Pages
From
Lymphedema Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Lymphedema Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 59 Pages
From
Herantis Pharma Plc (HRTIS) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Herantis Pharma Plc (HRTIS) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Herantis Pharma Oyj - Product Thumbnail Image

Herantis Pharma Oyj

  • Company Profile
  • 66 Pages
  • 14 Results (Page 1 of 1)
Loading Indicator
adroll